Literature DB >> 11074347

Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach.

C Schmitz1, P R Hof.   

Abstract

Any investigation of the total number of neurons in a given brain region must first address the following questions. What is the best method for estimating the total number of neurons? What are the validity and the expected precision of the obtained data? What precision must the estimates attain with respect to the scientific question? In the present study, these questions were addressed using a computer simulation. Virtual brain regions with various spatial distributions of virtual neurons were modeled. The total numbers of virtual neurons in the modeled brain regions were repeatedly estimated by simulation of modern design-based stereology, either by using the 'fractionator' method or by the established method based on the product of estimated neuron density and estimated volume of the reference space. We show that estimates of total numbers of neurons obtained using the fractionator are from a statistical and economical standpoint more efficient than corresponding estimates obtained using the density/volume procedure. Furthermore, the use of two simple prediction methods (one for homogeneous and the other for clustered neuron distributions) permits satisfactory predictions about the variation of presumably any estimates of total numbers of neurons obtained using the fractionator. Finally, we show that assessing the reliability of estimates of mean total neuronal numbers using the ratio between the mean of the squared coefficients of error of the estimates and the squared coefficient of variation of the estimated total neuronal numbers, a frequently employed method in stereological studies, is neither useful nor informative. The present results may constitute a new set of recommendations for the rigorous usage of design-based stereology. In particular, we strongly recommend counting considerably more neurons than is currently done in the literature when estimating total neuronal numbers using design-based stereology.

Mesh:

Year:  2000        PMID: 11074347     DOI: 10.1016/s0891-0618(00)00066-1

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  93 in total

1.  Prenatal PCBs disrupt early neuroendocrine development of the rat hypothalamus.

Authors:  Sarah M Dickerson; Stephanie L Cunningham; Andrea C Gore
Journal:  Toxicol Appl Pharmacol       Date:  2011-01-26       Impact factor: 4.219

2.  Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia.

Authors:  Patrick R Hof; Vahram Haroutunian; Christina Copland; Kenneth L Davis; Joseph D Buxbaum
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

3.  Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model.

Authors:  Caty Casas; Nicolas Sergeant; Jean-Michel Itier; Véronique Blanchard; Oliver Wirths; Nicolien van der Kolk; Valérie Vingtdeux; Evita van de Steeg; Gwenaëlle Ret; Thierry Canton; Hervé Drobecq; Allan Clark; Bruno Bonici; André Delacourte; Jesús Benavides; Christoph Schmitz; Günter Tremp; Thomas A Bayer; Patrick Benoit; Laurent Pradier
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

Review 4.  The use of design-based stereology to evaluate volumes and numbers in the liver: a review with practical guidelines.

Authors:  Ricardo Marcos; Rogério A F Monteiro; Eduardo Rocha
Journal:  J Anat       Date:  2012-02-01       Impact factor: 2.610

5.  Behavioral, neurochemical and histological alterations promoted by bilateral intranigral rotenone administration: a new approach for an old neurotoxin.

Authors:  Camila G Moreira; Janaína K Barbiero; Deborah Ariza; Patrícia A Dombrowski; Pamela Sabioni; Mariza Bortolanza; Claudio Da Cunha; Maria A B F Vital; Marcelo M S Lima
Journal:  Neurotox Res       Date:  2011-09-28       Impact factor: 3.911

6.  The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302.

Authors:  James P Apland; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Franco Rossetti; Steven L Miller; Maria F M Braga
Journal:  J Pharmacol Exp Ther       Date:  2014-08-25       Impact factor: 4.030

7.  Transgenic expression of intraneuronal Aβ42 but not Aβ40 leads to cellular Aβ lesions, degeneration, and functional impairment without typical Alzheimer's disease pathology.

Authors:  Dorothee Abramowski; Sabine Rabe; Ajeet Rijal Upadhaya; Julia Reichwald; Simone Danner; Dieter Staab; Estibaliz Capetillo-Zarate; Haruyasu Yamaguchi; Takaomi C Saido; Karl-Heinz Wiederhold; Dietmar Rudolf Thal; Matthias Staufenbiel
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

8.  Repeated Forced Swim Exacerbates Methamphetamine-Induced Neurotoxicity: Neuroprotective Effects of Nanowired Delivery of 5-HT3-Receptor Antagonist Ondansetron.

Authors:  José Vicente Lafuente; Aruna Sharma; Dafin F Muresanu; Asya Ozkizilcik; Z Ryan Tian; Ranjana Patnaik; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

9.  Three-dimensional and stereological characterization of the human substantia nigra during aging.

Authors:  Ana Tereza Di Lorenzo Alho; Claudia Kimie Suemoto; Lívia Polichiso; Edilaine Tampellini; Kátia Cristina de Oliveira; Mariana Molina; Glaucia Aparecida Bento Santos; Camila Nascimento; Renata Elaine Paraizo Leite; Renata Eloah de Lucena Ferreti-Rebustini; Alexandre Valotta da Silva; Ricardo Nitrini; Carlos Augusto Pasqualucci; Wilson Jacob-Filho; Helmut Heinsen; Lea Tenenholz Grinberg
Journal:  Brain Struct Funct       Date:  2015-09-19       Impact factor: 3.270

10.  Pathoarchitectonics of the cerebral cortex in chorea-acanthocytosis and Huntington's disease.

Authors:  J Liu; H Heinsen; L T Grinberg; E Alho; E Amaro; C A Pasqualucci; U Rüb; K Seidel; W den Dunnen; T Arzberger; C Schmitz; M C Kiessling; B Bader; A Danek
Journal:  Neuropathol Appl Neurobiol       Date:  2018-06-10       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.